Author:
Cryer Byron,Drossman Douglas A.,Chey William D.,Webster Lynn,Habibi Sepideh,Wang Martin
Funder
Sucampo Pharma Americas, LLC
Takeda Pharmaceuticals International
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Physiology
Reference34 articles.
1. Amitiza (lubiprostone) [package insert]. Deerfield, IL: Takeda Pharmaceuticals; 2016.
2. Lacy B, Levy L. Lubiprostone: a chloride channel activator. J Clin Gastroenterol. 2007;41:345–351.
3. Camilleri M, Bharucha A, Ueno R, et al. Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers. Am J Physiol Gastrointest Liver Physiol. 2006;290:G942–G947.
4. Fukudo S, Hongo M, Kaneko H, Takano M, Ueno R. Lubiprostone increases spontaneous bowel movement frequency and quality of life in patients with chronic idiopathic constipation. Clin Gastroenterol Hepatol. 2015;13:294.e295–301.e295.
5. Johanson J, Ueno R. Lubiprostone, a locally acting chloride channel activator, in adult patients with chronic constipation: a double-blind, placebo-controlled, dose-ranging study to evaluate efficacy and safety. Aliment Pharmacol Ther. 2007;25:1351–1361.
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献